Traxivitug

曲西韦塔单抗

Report date: 2024/01/04 14:48:36

Base Information

Drug NameTraxivitug
Drug Alias NameBK virus-specific antibodyMAU-868
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionCapsid protein inhibitors
TargetsCapsid protein
Therapy Area/IndicationsBK Polyomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesAmplyx Pharmaceuticals IncVera Therapeutics Inc
Inactive CompaniesNovartis Pharma Ag
Active IndicationsBK Polyomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A